NEW YORK (VINnews) — Massachusets-based biotech company Moderna announced Tuesday that a potential COVID-19 vaccine it has been testing has produced a “robust” immune response in all the patients participating in the early vaccine trials. The company gave three groups of 45 patients the trial vaccine in different dosages. Preliminary data from the trials were […]